← Back to patent-cliff list

Ibogaine

Tier C — Watch / trade

Ibogaine

-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:DAT, MOR1, KOR1, SERT

Indications (approved):Alcohol abuse, Post-traumatic stress disorder, Traumatic brain injury, 脑损伤, Mild cognitive impairment

Regional status

US
Discontinued
2025-09-01
EU
-
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 2 · Total yield /
Voacangine—API · Ibogaine
CodeCAS No.Intermediate
Voacangine-methyl (6S,6aS,7S,9S)-7-ethyl-2-methoxy-7,8,9,10,12,13-hexahydro-5H-6,9-methanopyrido[1',2':1,2]azepino[4,5-b]indole-6(6aH)-carboxylate

Frequently asked questions

What are the approved indications of Ibogaine?

Approved indications include: Alcohol abuse, Post-traumatic stress disorder, Traumatic brain injury, 脑损伤, Mild cognitive impairment.

When does the Ibogaine patent expire?

No public expiry year is available for Ibogaine yet; this page updates once verified.

How many synthesis routes are recorded for Ibogaine?

1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Ibogaine intermediates?

All intermediates in Ibogaine routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Ibogaine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-22